Skip to main content

and
  1. Article

    Open Access

    Stathmin 1 is a biomarker for diagnosis of microvascular invasion to predict prognosis of early hepatocellular carcinoma

    Microvascular invasion (MVI) is presently evaluated as a high-risk factor to be directly relative to postoperative prognosis of hepatocellular carcinoma (HCC). Up to now, diagnosis of MVI mainly depends on the...

    Yongchao Cai, Yong Fu, Changcheng Liu, **cheng Wang, Pu You in Cell Death & Disease (2022)

  2. Article

    Open Access

    The extent of liver injury determines hepatocyte fate toward senescence or cancer

    It is well known that induction of hepatocyte senescence could inhibit the development of hepatocellular carcinoma (HCC). Until now, it is still unclear how the degree of liver injury dictates hepatocyte senes...

    Chao Wang, Wen-Jian Chen, Ying-Fu Wu, Pu You, Shang-Yong Zheng in Cell Death & Disease (2018)

  3. Article

    Reversible transition between hepatocytes and liver progenitors for in vitro hepatocyte expansion

    Han Wu, Xu Zhou, Gong-Bo Fu, Zhi-Ying He, Hong-** Wu, Pu You in Cell Research (2017)

  4. No Access

    Article

    A potential role for the homeoprotein Hhex in hepatocellular carcinoma progression

    Hepatocellular carcinoma (HCC), the most common primary malignant tumor of the liver, often associated with the dysregulation of transcriptional pathways involved in cell growth and differentiation. The hemato...

    Juan Su, Pu You, Jun-Peng Zhao, Shou-Long Zhang, Shao-Hua Song in Medical Oncology (2012)